Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-426-5 | CAS number: 26040-51-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: In this guideline study according to OECD TG 407 and GLP reproductive organs of male and female rats were examined for adverse effects.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
- Principles of method if other than guideline:
- Bis(2-ethylhexyl) tetrabromophthalate was administered via the diet to three groups of ten male and ten female CD rats at concentrations of 200, 2 000 or 20 000 ppm (= ca. 21.97, 223.4 or 2331 mg/kg/day) for four weeks. At the end of the treatment period all animals were killed and necropsied. The pathologic evaluation consisted of organ weight, gross and microscopic examination of reproductive organs, incl. epididymides, mammary glands - caudal, ovaries, prostate, testes, and uterus (with cervix).
- GLP compliance:
- yes
- Type of method:
- in vivo
Test material
- Reference substance name:
- Bis(2-ethylhexyl) tetrabromophthalate
- EC Number:
- 247-426-5
- EC Name:
- Bis(2-ethylhexyl) tetrabromophthalate
- Cas Number:
- 26040-51-7
- Molecular formula:
- C24H34Br4O4
- IUPAC Name:
- 1,2-bis(2-ethylhexyl) 3,4,5,6-tetrabromobenzene-1,2-dicarboxylate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CD rats
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: feed
- Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 21.97 mg/kg bw/day
- Dose / conc.:
- 223.4 mg/kg bw/day
- Dose / conc.:
- 2 331 mg/kg bw/day
- No. of animals per sex per dose:
- Three groups of ten male and ten female CD rats per dose
- Control animals:
- other: A positive control group of five male and five female CD rats received di-2-ethyl hexyl phthalate (DEHP) via the diet at a concentration of 15 000 ppm for four weeks.
Results and discussion
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 2 331 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- histopathology: non-neoplastic
Any other information on results incl. tables
Bis(2-ethylhexyl) tetrabromophthalate:
There were no signs of reaction to treatment with FR-45B. Slightly low overall bodyweight gain was recorded for females receiving the highest dietary concentration of FR-458. Males treated with FR-458 were unaffected. Marginally low alanine amino-transferase activities were seen in females receiving the highest dietary concentration of FR-458, and marginally low phosphorus concentrations were seen in all females and males receiving the highest dietary concentration of FR-458. Urinary composition was unaffected by treatment with FR-458.
There were no organ weight changes and no treatment-related histopathological changes in rats that received FR-458.
Di-2 -ethylhexylphthalate (DEHP) - positive control substance:
Hairloss from the dorsal surface of rats receiving DEHP was recorded from the second week of treatment. Markedly low food consumption and bodyweight gain, and high food conversion ratio, were recorded for rats receiving DEHP. Rats receiving DEHP had higher platelet numbers than controls. Changes in rats receiving DEHP were minor and comprised high alkaline phosphatase activities, urea and albumin concentrations and albumin to globulin ratios in males, and low alanine and aspartate amino-transferase activities in females.
Organ weight analysis indicated markedly high liver and markedly low testes weights in rats receiving DEHP. At necropsy males receiving DEHP were found to have small, flaccid testes. Histopathological changes in animals that received DEHP comprised panacinar hepatocytic granular eosinophilic extensive cytoplasm in males and females, a lack of centriacinar hepatocytic glycogen in males, and a lack of germinal epithelium in the testes.
Applicant's summary and conclusion
- Conclusions:
- No clinical signs and no organ weight changes and histopathological changes in reproductive organs were found in male and female rats treated with 200, 2 000 or 20 000 ppm (= ca. 21.97, 223.4 or 2331 mg/kg/day) bis(2-ethylhexyl) tetrabromophthalate.
Therefore, the NOAEL for fertility is 20 000 ppm (ca. 2331 mg/kg bw). - Executive summary:
Bis(2-ethylhexyl) tetrabromophthalate was administered via the diet to three groups of ten male and ten female CD rats at concentrations of 200, 2 000 or 20 000 ppm (= ca. 21.97, 223.4 or 2331 mg/kg/day) for four weeks. At the end of the treatment period all animals were killed and necropsied. The pathologic evaluation consisted of organ weight, gross and microscopic examination of reproductive organs, incl. epididymides, mammary glands - caudal, ovaries, prostate, testes, and uterus (with cervix).
No clinical signs and no organ weight changes and histopathological changes in reproductive organs were found in male and female rats treated with 200, 2 000 or 20 000 ppm (= ca. 21.97, 223.4 or 2331 mg/kg/day) bis(2-ethylhexyl) tetrabromophthalate.
Therefore, the NOAEL for fertility is 20 000 ppm (ca. 2331 mg/kg bw).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Sellel veebilehel kasutatakse küpsiseid, et tagada lehe parim kasutus.